Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 11/20 | 0.50 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.46 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 2/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29111409 | 0.87 | ERN1 (0.56) | ERN1TRIM24TRIM33KDM4ERAB9A | |
| Fomecin B SCHEMBL11039474 | 0.85 | ERN1 (0.54) | ERN1TRIM24TRIM33KDM4EMEN1 | |
| SCHEMBL548457 | 0.84 | TDP1 (0.50) | ERN1TRIM24TRIM33MEN1KMT2A | |
| SCHEMBL10748907 | 0.83 | ERN1 (0.52) | ERN1TRIM24TRIM33KDM4EMEN1 | |
| SCHEMBL1302180 | 0.78 | ERN1 (0.64) | ERN1TRIM24TRIM33MEN1RAB9A | |
| SCHEMBL7939012 | 0.74 | CA1 (0.59) | ERN1TRIM24TRIM33TYR | |
| SCHEMBL31236213 | 0.74 | ERN1 (0.61) | ERN1 | |
| SCHEMBL2790223 | 0.74 | TRIM24 (0.50) | ERN1TRIM24TRIM33KDM4EMEN1 | |
| SCHEMBL29459661 | 0.74 | ERN1 (0.50) | ERN1TRIM24TRIM33KDM4ERAB9A | |
| SCHEMBL1002739 | 0.74 | ERN1 (0.50) | ERN1TRIM24TRIM33KDM4ERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113933501-A | Immunomagnetic bead and preparation method and application thereof | 吉林中科研伸科技有限公司 | 2022-01-14 | — | — | CN | claimed |
| CN-114752028-B | Solvent-free preparation method and application of covalent organic framework COFs film | 广西师范大学 | 2023-04-18 | — | — | CN | disclosed |
| CN-115101349-A | Flexible self-supporting covalent organic framework fibrous membrane and preparation method and application thereof | 上海大学 | 2022-09-23 | — | — | CN | disclosed |
| CN-114752028-A | Solvent-free preparation method and application of covalent organic framework COFs film | 广西师范大学 | 2022-07-15 | — | — | CN | disclosed |
| CN-114713286-A | Ti-MOFs @ COFs hybrid material with stable core-shell structure and preparation method and application thereof | 中南大学 | 2022-07-08 | — | — | CN | disclosed |
| US-7858819-B2 | Tris(formylphenyl) and novel polynuclear phenol derived therefrom | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20100099908-A1 | TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-0044260-B1 | PROCESS FOR THE PREPARATION OF POLYPHENOLS OPTIONALLY SUBSTITUTED BY AN ALDEHYDE GROUP | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-04-11 | — | — | EP | disclosed |
| US-4435601-A | OXIDATION WITH HYDROGEN PEROXIDE IN ALKALI OR ALKALINE METAL BASE | RHONE-POULENC INDUSTRIES (FR) | 1984-03-06 | — | — | US | disclosed |
| EP-0044260-A2 | Process for the preparation of polyphenols optionally substituted by an aldehyde group | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099908-A1 | TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM | AS3MT, RRM2, SHROOM3 | ERN1 3506/4885TRIM24 2466/4885TRIM33 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.